A. Craniocaudal and B. mediolateral oblique digital breast tomosynthesis images...
A. Craniocaudal and B. mediolateral oblique digital breast tomosynthesis images demonstrate two areas of AD in upper outer left breast (circles) that persisted on additional diagnostic tomosynthesis images (not shown). C. Transverse greyscale ultrasound image of upper outer breast shows irregular hypoechoic mass with associated AD at 12:30 (arrow), corresponding to posterior AD. No ultrasound correlate was identified for anterior AD. Ultrasound-guided biopsy of posterior AD revealed malignancy (invasive lobular carcinoma). Tomosynthesis-guided biopsy of anterior AD yielded benign pathology (stromal fibrosis).

Image credit: ARRS/AJR

News • High-risk pathology identification

Single vs. multiple architectural distortion on digital breast tomosynthesis

According to the American Journal of Roentgenology (AJR), for patients with multiple architectural distortion (AD) identified on digital breast tomosynthesis (DBT), biopsy of all areas may be warranted, given the variation of pathologic diagnoses across AD in individual patients.

“Multiple AD, compared with single AD, was significantly more likely to yield high-risk pathology, but there was no significant difference in yield of malignancy,” wrote corresponding author Lilian C. Wang, MD, of Northwestern Medicine. “In patients with multiple AD, multiple ipsilateral or contralateral AD commonly varied in pathologic classification: benign, high risk, or malignant.” 

Wang and colleagues’ retrospective study, published in the American Journal of Roentgenology, included 402 patients (mean age, 56 years) who underwent image-guided core needle biopsy of AD visualized on DBT between April 7, 2017, and April 16, 2019. Patients were grouped in the single or multiple AD cohort based on the presence of distinct AD areas noted in the clinical report, while the pathologic diagnosis for each AD was based on the most aggressive pathology identified on either biopsy or surgical excision (if performed). 

Ultimately, compared with single AD, multiple AD showed a higher frequency of high-risk pathology (53.0% vs. 32.5%, p=.002) but no significantly different frequency of malignancy on a per-lesion or per-patient basis (31.8% vs. 28.2%, p=.56). In 8/24 patients with ≥2 ipsilateral biopsied AD, the ipsilateral areas varied in terms of most aggressive pathology; in 5/10 patients with contralateral biopsied AD, the contralateral areas varied in most aggressive pathology. “To our knowledge,” the authors of this AJR article contended, “this is the first study to compare pathologic outcomes between patients with single and multiple AD visualized by DBT.” 


Source: American Roentgen Ray Society

28.07.2022

Read all latest stories

Related articles

Photo

News • DBT vs. standard digital mammography

Huge study shows: Tomosynthesis better at breast cancer detection

In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone.

Photo

Article • Digital breast tomosynthesis (DBT)

New EU recommendations for breast screening enhance opportunities for early detection

Mammography has been an essential imaging technology for breast cancer detection for decades. As the industry has continued to innovate, one advancement in mammography has particularly changed the…

Photo

Article • Multiparametric ultrasound

Experts assess usefulness of MPUS in the diagnostic conundrum

Multiparametric ultrasound (MPUS) has proven its value in the abdomen – now, the technique is increasingly moving towards peripheral areas such as breast and testis imaging, experts showed in a…

Related products

Amulet Innovality

Tomosynthesis

Fujifilm · Amulet Innovality

FUJIFILM Europe GmbH
Amulet Bellus II

Mammo Workstations

Fujifilm · Amulet Bellus II

FUJIFILM Europe GmbH
Amulet Innovality Harmony

Tomosynthesis

Fujifilm · Amulet Innovality Harmony

FUJIFILM Europe GmbH
Brevera

Biopsy Units

Hologic · Brevera

Hologic, Inc.
Subscribe to Newsletter